The EMA validation of T-DXd with pertuzumab could change the standard of care for HER2-positive metastatic breast cancer in ...
In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...
In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...
New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...
Danish biotechnology company Genmab has announced top line results from the Phase III EPCORE DLBCL-1 trial, highlighting ...
Should we use AI to pre-screen whether people can see a human therapist? And should we use AI to do initial intervention?
Data from the COMMIT trial demonstrated that the addition of oxaliplatin, leucovorin, 5-fluorouracil (mFOLFOX6) and ...
2d
New research bolsters evidence that Tylenol doesn't raise the risk of autism despite Trump's claims
The latest work adds to the growing body of research refuting claims made by the Trump administration last year when the ...
CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...
The review looked at more than three dozen studies and found no evidence that acetaminophen increased the risk of ...
If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...
Investigators evaluated the efficacy and safety of toripalimab versus dacarbazine as the first-line treatment in advanced melanoma predominantly of acral subtype.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback